

Health Library
October 10, 2025
Question on this topic? Get an instant answer from August.
Mosunetuzumab is a targeted cancer treatment that helps your immune system fight certain blood cancers. This medication works by connecting your body's natural defense cells to cancer cells, making it easier for your immune system to recognize and destroy them.
If you or someone you care about has been prescribed this medication, you likely have questions about how it works and what to expect. Let's walk through everything you need to know about mosunetuzumab in clear, straightforward terms.
Mosunetuzumab is a type of immunotherapy called a bispecific antibody. Think of it as a molecular bridge that connects two different types of cells in your body.
This medication specifically targets B-cell lymphomas, which are cancers that affect certain white blood cells. The drug works by attaching to both the cancer cells and your immune system's T-cells, bringing them close together so your immune system can better attack the cancer.
The brand name for this medication is Lunsumio, and it's given through an intravenous (IV) infusion in a healthcare setting. Your medical team will always supervise these treatments to ensure your safety and comfort.
Mosunetuzumab treats adults with follicular lymphoma that has returned after previous treatments. Follicular lymphoma is a type of non-Hodgkin's lymphoma that affects your lymph nodes and other parts of your lymphatic system.
Your doctor might recommend this treatment if you've already tried at least two other systemic therapies that didn't work as well as hoped. It's considered a targeted therapy because it specifically goes after the cancer cells while trying to spare healthy cells.
This medication is typically reserved for cases where other treatments haven't been successful. Your oncologist will carefully evaluate whether this treatment is right for your specific situation and medical history.
Mosunetuzumab works by recruiting your body's own immune system to fight cancer. It's designed to bind to two different targets at once - the CD20 protein on cancer cells and the CD3 protein on your T-cells.
When the medication connects these cells, it activates your T-cells and directs them to attack the cancer cells. This process is called T-cell redirection, and it can help your immune system recognize cancer cells it might have missed before.
This is considered a moderately strong cancer treatment that works differently from traditional chemotherapy. Instead of directly killing cancer cells with toxic chemicals, it enhances your immune system's natural ability to fight the disease.
Mosunetuzumab is given as an intravenous infusion in a hospital or cancer treatment center. You cannot take this medication at home - it requires professional medical supervision.
Before each infusion, your healthcare team will likely give you medications to help prevent infusion reactions. These might include acetaminophen, antihistamines, or corticosteroids to help your body tolerate the treatment better.
The infusion itself typically takes several hours, and you'll be monitored closely during and after the treatment. Your medical team will watch for any signs of reactions and adjust the infusion rate if needed. You don't need to eat specific foods before treatment, but staying well-hydrated is generally helpful.
The treatment schedule for mosunetuzumab follows a specific pattern that your oncologist will explain in detail. Most patients receive treatments in cycles, with each cycle lasting about 21 days.
During the first cycle, you'll typically receive three doses over the course of three weeks. After that, you'll usually get one dose every three weeks for additional cycles. The total duration depends on how well the treatment works and how your body responds.
Your doctor will regularly monitor your progress through blood tests and imaging studies. Treatment continues as long as it's working and you're tolerating it well. Some patients may receive treatment for several months or longer, depending on their individual response.
Like all cancer treatments, mosunetuzumab can cause side effects, though not everyone experiences them. Most side effects are manageable with proper medical care and monitoring.
Understanding what to expect can help you feel more prepared and know when to contact your healthcare team. Here are the most common side effects you might experience:
These common side effects are usually mild to moderate and often improve as your body adjusts to the treatment. Your healthcare team has experience managing these symptoms and can provide medications or strategies to help you feel better.
More serious side effects can occur, though they're less common. These require immediate medical attention and careful monitoring:
Your medical team will monitor you closely for these serious side effects, especially during your first few treatments. They're well-prepared to manage these complications if they occur.
Certain people should not receive mosunetuzumab due to safety concerns. Your doctor will carefully review your medical history before recommending this treatment.
You should not receive this medication if you have a known severe allergy to mosunetuzumab or any of its ingredients. Your healthcare team will discuss any previous allergic reactions you've had to medications or treatments.
Special caution is needed if you have active infections, severe heart problems, or significant liver or kidney disease. Pregnant or breastfeeding women should not receive this treatment, as it could harm the baby. Your doctor will also consider other medications you're taking that might interact with mosunetuzumab.
The brand name for mosunetuzumab is Lunsumio. This medication is manufactured by Genentech, a member of the Roche Group.
When you receive your treatment, you'll see "Lunsumio" on the medication labels and treatment paperwork. The full generic name is mosunetuzumab-axgb, which includes letters that identify the specific manufacturer.
Your insurance company and healthcare team will use both the brand name and generic name when discussing your treatment and coverage options.
Several other treatments are available for follicular lymphoma, depending on your specific situation and previous treatments. Your oncologist will consider various factors when choosing the best option for you.
Other targeted therapies include rituximab-based combinations, which have been used successfully for many years. CAR-T cell therapy is another immunotherapy option that might be considered in certain cases.
Traditional chemotherapy regimens, radiation therapy, and other newer immunotherapies might also be options. Your doctor will discuss these alternatives based on your medical history, current health status, and how your cancer has responded to previous treatments.
Mosunetuzumab and rituximab work differently and are used in different situations, so it's not always a direct comparison. Rituximab has been used successfully for many years and has a well-established safety profile.
Mosunetuzumab may be recommended when rituximab-based treatments haven't worked well or have stopped working. Because it works through a different mechanism - connecting T-cells to cancer cells - it might be effective even when other treatments haven't been.
Your oncologist will consider your specific medical history, previous treatments, and current health status when deciding which treatment is most appropriate. The "better" treatment is the one that works best for your individual situation with manageable side effects.
Is Mosunetuzumab Safe for People with Heart Disease?
People with heart disease need special consideration before receiving mosunetuzumab. The medication can cause cytokine release syndrome, which may affect blood pressure and heart function.
Your cardiologist and oncologist will work together to evaluate whether this treatment is safe for you. They might recommend additional heart monitoring during treatment or adjustments to your heart medications. Don't hesitate to discuss any heart concerns with your healthcare team.
What Should I Do if I Accidentally Receive Too Much Mosunetuzumab?
Since mosunetuzumab is given in a controlled medical setting, accidental overdoses are extremely rare. Your healthcare team carefully calculates and monitors every dose.
If you're concerned about the dose you received, speak with your medical team immediately. They can review your treatment records and monitor you more closely if needed. The medication is given slowly over several hours, which allows for careful monitoring throughout the process.
What Should I Do if I Miss a Dose of Mosunetuzumab?
If you miss a scheduled treatment, contact your oncology team as soon as possible to reschedule. They'll determine the best timing for your next dose based on your treatment schedule.
Missing a dose doesn't mean you have to start over, but it's important to maintain your treatment schedule as closely as possible. Your medical team will adjust your schedule and monitor you appropriately to ensure you receive the full benefit of treatment.
When Can I Stop Taking Mosunetuzumab?
You should never stop mosunetuzumab treatment without discussing it with your oncologist first. The decision to stop depends on how well the treatment is working and how you're tolerating it.
Your doctor will regularly evaluate your progress through scans, blood tests, and physical exams. Treatment typically continues as long as it's helping and the side effects are manageable. If the cancer progresses or side effects become too severe, your doctor will discuss other treatment options with you.
Can I Receive Vaccines While Taking Mosunetuzumab?
Vaccination timing needs careful consideration while you're receiving mosunetuzumab. Live vaccines should be avoided, but inactivated vaccines might be recommended in some cases.
Your healthcare team will advise you about which vaccines are safe and when to receive them. They might recommend certain vaccines before starting treatment or suggest waiting until after treatment is complete. Always check with your medical team before receiving any vaccinations.
6Mpeople
Get clear medical guidance
on symptoms, medications, and lab reports.